1.
Riccardi VM: Neurofibromatosis: Clinical heterogeneity. Curr Probl Cancer 1982;7:1–34.
2.
Cooke JV: Familial white skin spotting (piebaldism; ‘partial albinism’) with white forelock. J Pediatr 1952;41:1–12.
3.
National Institutes of Health Consensus Development conference: Neurofibromatosis conference statement. Arch Neurol 1988;45:575–578.
4.
Chang T, McGrae JD, Hashimoto K: Ultrastructural study of two patients with both piebaldism and neurofibromatosis 1. Pediatr Dermatol 1993;10:224–234.
5.
Riccardi VM, Eichner JE: Non-von Recklinghausen NF; in Riccardi VM, Eichner JE (eds): Neurofibromatosis: Phenotype, Natural History and Pathogenesis. Baltimore, John Hopkins University Press, 1986.
6.
Ledbetter DH, Rich DC, O’Connel P, Leppert M, Carey JC: Precise local-zation of NF-1 to 17q11.2 by balanced translocation. Am J Hum Genet 1989;44:20–24.
7.
Morrison-Graham K, Takahasyi Y: Steel factor and c-Kit receptor: From mutants to a growth factor system. Bioessays 1993;15:77–83.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.